Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anti-Infective Agents | 2 | 2015 | 983 | 0.570 |
Why?
|
| Pneumonia | 2 | 2015 | 2143 | 0.420 |
Why?
|
| Geotrichosis | 1 | 2009 | 2 | 0.350 |
Why?
|
| Geotrichum | 1 | 2009 | 4 | 0.350 |
Why?
|
| Adenoviridae | 3 | 2007 | 1084 | 0.310 |
Why?
|
| Vaccines, Synthetic | 2 | 2007 | 616 | 0.280 |
Why?
|
| Adenovirus Infections, Human | 1 | 2006 | 73 | 0.260 |
Why?
|
| Adenoviruses, Human | 1 | 2006 | 255 | 0.240 |
Why?
|
| Cross Reactions | 1 | 2006 | 817 | 0.240 |
Why?
|
| Genetic Vectors | 3 | 2007 | 3395 | 0.210 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1600 | 0.180 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 4806 | 0.180 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 1998 | 19 | 0.160 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2001 | 237 | 0.160 |
Why?
|
| Encephalitozoon cuniculi | 1 | 2017 | 5 | 0.140 |
Why?
|
| Microsporidiosis | 1 | 2017 | 23 | 0.140 |
Why?
|
| Leg | 1 | 2001 | 1088 | 0.130 |
Why?
|
| Antibodies, Viral | 1 | 2006 | 3156 | 0.120 |
Why?
|
| Femur | 1 | 2001 | 1307 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2010 | 3613 | 0.120 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2003 | 1897 | 0.110 |
Why?
|
| Encephalitis | 1 | 2017 | 438 | 0.110 |
Why?
|
| Capsid Proteins | 2 | 2006 | 468 | 0.110 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2001 | 1159 | 0.100 |
Why?
|
| Drug Administration Schedule | 2 | 2014 | 4853 | 0.100 |
Why?
|
| Micrococcaceae | 1 | 2010 | 8 | 0.090 |
Why?
|
| Community-Acquired Infections | 1 | 2014 | 469 | 0.090 |
Why?
|
| Neutralization Tests | 3 | 2007 | 728 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2001 | 2529 | 0.080 |
Why?
|
| Seroepidemiologic Studies | 2 | 2007 | 397 | 0.080 |
Why?
|
| Dermatitis | 1 | 2010 | 202 | 0.080 |
Why?
|
| Aging | 1 | 2006 | 8708 | 0.070 |
Why?
|
| Tissue Donors | 1 | 2017 | 2331 | 0.070 |
Why?
|
| Africa South of the Sahara | 2 | 2007 | 744 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2003 | 4527 | 0.070 |
Why?
|
| Adenoviridae Infections | 1 | 2007 | 93 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2017 | 2330 | 0.060 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 527 | 0.060 |
Why?
|
| Antifungal Agents | 1 | 2009 | 752 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 1705 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2017 | 3233 | 0.050 |
Why?
|
| Bacteremia | 1 | 2010 | 979 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 7390 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2006 | 988 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2017 | 4234 | 0.050 |
Why?
|
| Viral Vaccines | 1 | 2007 | 596 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2006 | 933 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2006 | 1351 | 0.040 |
Why?
|
| Antibodies | 1 | 2006 | 2418 | 0.040 |
Why?
|
| Recurrence | 1 | 2009 | 8465 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2003 | 2571 | 0.030 |
Why?
|
| HIV Infections | 1 | 2003 | 17351 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10723 | 0.030 |
Why?
|
| Graves Disease | 1 | 1996 | 238 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2003 | 2199 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2007 | 22169 | 0.030 |
Why?
|
| Humans | 11 | 2017 | 761504 | 0.030 |
Why?
|
| Viral Load | 1 | 2003 | 3332 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 1834 | 0.020 |
Why?
|
| Actinomycetales Infections | 1 | 2010 | 30 | 0.020 |
Why?
|
| Macaca mulatta | 2 | 2007 | 2329 | 0.020 |
Why?
|
| Sex Factors | 1 | 2003 | 10552 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 2010 | 376 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2010 | 503 | 0.020 |
Why?
|
| Serotyping | 1 | 2007 | 325 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2006 | 455 | 0.020 |
Why?
|
| HIV-1 | 1 | 2003 | 6863 | 0.020 |
Why?
|
| Mice | 3 | 2007 | 81525 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 856 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 36192 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 42230 | 0.010 |
Why?
|
| DNA Primers | 1 | 2007 | 2819 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 4174 | 0.010 |
Why?
|
| Female | 4 | 2017 | 392644 | 0.010 |
Why?
|
| Animals | 3 | 2007 | 168459 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1998 | 7407 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3810 | 0.010 |
Why?
|
| Middle Aged | 3 | 2010 | 220895 | 0.010 |
Why?
|
| Child | 1 | 2006 | 80153 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 88319 | 0.010 |
Why?
|
| Biopsy | 1 | 2010 | 6766 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 20570 | 0.010 |
Why?
|
| Vaccines | 1 | 2006 | 844 | 0.010 |
Why?
|
| Skin | 1 | 2010 | 4484 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 4740 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 12441 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 17635 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 1996 | 294 | 0.010 |
Why?
|
| Self-Assessment | 1 | 1996 | 396 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 4580 | 0.010 |
Why?
|
| Aged | 2 | 2001 | 169289 | 0.010 |
Why?
|
| Male | 3 | 2017 | 360804 | 0.000 |
Why?
|
| Neuropsychological Tests | 1 | 1996 | 7045 | 0.000 |
Why?
|
| Cognition Disorders | 1 | 1996 | 3979 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1996 | 12974 | 0.000 |
Why?
|
| Adult | 1 | 1996 | 221177 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_